Advances in the Use of Retinoids in Cancer Therapy and Prevention

Research output: Chapter in Book/Report/Conference proceedingChapter


Retinoids are natural and synthetic derivatives of vitamin A. The anticancer properties of retinoids have long been investigated in the preclinical, epidemiological and clinical settings. It is recognized that retinoids have potent, widespread and, in many ways, unprecedented anticancer activities. This chapter summarizes the current use of retinoids as cancer agents with emphasis on recent clinical advances and mechanistic insights for their optimal clinical utility. Promising results from a prospective randomized trial for the prevention of secondary hepatocellular carcinomas have been demonstrated with the acyclic retinoid polyprenoic acid. Retinoids have been tested for prevention of secondary cancers in head and neck and lung cancer. Systematic study of retinoid scheduling in animal models and phase 0 clinical trials may prove to be a fruitful approach to optimize retinoid use in the clinic. One approach to increase the efficacy of retinoids in advanced cancer is through combination therapy.

Original languageEnglish (US)
Title of host publicationThe Retinoids
Subtitle of host publicationBiology, Biochemistry, and Disease
Number of pages18
ISBN (Electronic)9781118628003
ISBN (Print)9781118627983
StatePublished - Jun 12 2015
Externally publishedYes


  • Animal models
  • Anticancer properties
  • Hepatocellular carcinomas
  • Lung cancer
  • Polyprenoic acid
  • Retinoids

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Advances in the Use of Retinoids in Cancer Therapy and Prevention'. Together they form a unique fingerprint.

Cite this